Human recombinant cementum protein 1, dental pulp stem cells, and PLGA/hydroxyapatite scaffold as substitute biomaterial in critical size osseous defect repair in vivo
Autores organización
Autores
- Colorado C
- Durán C
Grupos de investigación
Resumen
Objective: To evaluate the healing response of critical defects in rat calvaria with recombinant cementum protein 1 (hrCEMP-1) combined with human dental pulp stem cells (hDPSC) and polylactide-co-glycolide/hydroxyapatite (PLGA/HA) scaffold. Methods: The effect of hrCEMP-1 on proliferation and differentiation of human dental stem cells (hDPSCs) toward a mineralizing-like phenotype was evaluated in monolayer and PLGA/HA scaffold by qPCR. 5 mm calvarial defects were created in Wistar rats and filled with: 1) PLGA/HA scaffold; 2) hDPSCs-PLGA/HA scaffold; 3) hrCEMP-1-hDPSc-PLGA/HA scaffold; 4) control (without scaffold). Bone formation was evaluated by histological-histomorphometric analysis, scanning electron microscopy (SEM) and radiographic evaluation. Comparisons between groups were made with a one-way analysis of variance ANOVA and Bonferroni post-hoc test. Results: In vitro results showed that the PLGA/HA scaffold loaded with hrCEMP-1 improved the proliferation and differentiation of hDPSCs towards a mineralization phenotype by inducing mRNA expression of ALP, OSX, RUNX2, OP, and COL-I genes. The hrCEMP-1/hDPSCs/-PLGA/HA scaffold resulted only in connective tissue formed after ten weeks of healing, larger central radiolucency, and a low peripheral density. We showed superior bone growth and repair with a PLGA/HA matrix scaffold alone and containing hDPSCs compared to the hrCEMP/cells group. Conclusions: PLGA/HA scaffold with hrCEMP-1 induces hDPSC commitment to mineralizing phenotype in vitro, but does not promote critical size osseous defect repair in vivo when it is included in a substitute biomaterial with hDPSc-PLGA/HA scaffold. © 2022
Copyright © 2022. Published by Elsevier Ltd.
Datos de la publicación
- ISSN/ISSNe:
- 0003-9969, 1879-1506
- Tipo:
- Article
- Páginas:
- 105392-105392
- Enlace a otro recurso:
- www.scopus.com
Archives Of Oral Biology Elsevier Ltd
Citas Recibidas en Web of Science: 2
Citas Recibidas en Scopus: 6
Documentos
- No hay documentos
Filiaciones
Keywords
- Animals; Biocompatible Materials; Cell Differentiation; Dental Cementum; Dental Pulp; Durapatite; Humans; Osteogenesis; Rats; Rats, Wistar; Skull; Stem Cells; Tissue Scaffolds; biomaterial; hydroxyapatite; animal; bone development; cell differentiation; human; rat; skull; stem cell; tissue scaffold; tooth cementum; tooth pulp; Wistar rat
Proyectos asociados
Desarrollo de un producto antimicrobiano con base en propóleos para uso odontológico en Endodoncia. Fase I estudios Fitoquímicos, Citotóxicos y Antimicrobianos.
Investigador Principal: YORMARIS CASTILLO ROMERO
PCI-2018-10160 . 2019
Comparación de la inducción de diferenciación de células madre mesenquimales y pre-osteoblastos cultivados con medio condicionado o co-cultivados in vitro.
Investigador Principal: LINA MARIA ESCOBAR MARQUEZ
PCI-2022-11044 . 2022
Desarrollo de sondas de ADN genómico para la evaluación de bacterias cultivables y no cultivables del microbioma oral en pacientes con periodontitis de Colombia y España
Investigador Principal: GLORIA INES LAFAURIE VILLAMIL
UEB-2018-480 . 2018
Desarrollo de un modelo de epitelio asociado a folículo ( FAE ) en ambiente HLA-B27 positivo: una aproximación para en estudio in vitro de transcitosis reversa de SIgA en las espondiloartritis
Investigador Principal: JULIETTE DE AVILA QUIROGA
UEB-2019-517 . 2019
Desarrollo de un sistema de hipertermia a frecuencia de microondas para el tratamiento de cáncer de mama con monitoreo de temperatura
Investigador Principal: HECTOR FABIAN GUARNIZO MENDEZ
UEB-2019-524 . 2019
Citar la publicación
Colorado C,Escobar LM,Lafaurie GI,Durán C,Perdomo SJ. Human recombinant cementum protein 1, dental pulp stem cells, and PLGA/hydroxyapatite scaffold as substitute biomaterial in critical size osseous defect repair in vivo. Arch Oral Biol. 2022. 137. p. 105392-105392. IF:3,000. (2).